Treatment OutcomeOutcome Assessment (Health Care)Retrospective StudiesFollow-Up StudiesPregnancy OutcomePrognosisProspective StudiesTime FactorsAntitubercular AgentsComparative Effectiveness ResearchCost-Benefit AnalysisCognitive TherapyOutcome and Process Assessment (Health Care)Randomized Controlled Trials as TopicCohort StudiesDirectly Observed TherapyRisk FactorsTreatment FailureCombined Modality TherapySeverity of Illness IndexPatient ComplianceSurvival AnalysisRecurrenceSurvival RatePredictive Value of TestsTuberculosis, PulmonaryQuality of LifePregnancyUnited StatesExtensively Drug-Resistant TuberculosisDrug Therapy, CombinationPsychotherapyTuberculosis, Multidrug-ResistantResearch DesignHIV InfectionsSubstance-Related DisordersPatient SatisfactionInfant, NewbornMultivariate AnalysisLogistic ModelsBuprenorphineAge FactorsKaplan-Meier EstimateProgram EvaluationOpioid-Related DisordersSubstance Abuse Treatment CentersRisk AssessmentAlcoholismClinical Trials as TopicNeoplasm StagingTuberculosisPsychiatric Status Rating ScalesAntineoplastic Combined Chemotherapy ProtocolsTemperanceBehavior TherapyPatient DropoutsReproducibility of ResultsHospitals, Chronic DiseaseClinical ProtocolsPilot ProjectsPostoperative ComplicationsRemission InductionPain MeasurementImplosive TherapyLongitudinal StudiesEvidence-Based MedicinePatient SelectionIncidenceQuestionnairesRegression AnalysisMedication AdherenceMethadoneAnalysis of VarianceChi-Square DistributionDisease-Free SurvivalDepressive Disorder, MajorCocaine-Related DisordersDouble-Blind MethodRetreatmentMotivationProportional Hazards ModelsResidential TreatmentGreat BritainAnti-HIV AgentsChronic DiseaseQuality-Adjusted Life YearsRecovery of FunctionAnti-Retroviral AgentsAntidepressive AgentsAcute DiseaseGenotypePain ManagementStatistics, NonparametricDisease ProgressionLength of StayAmbulatory CareNeoplasm Recurrence, LocalAntineoplastic AgentsSex FactorsCoinfection